Acute myocardial infarction
Therapeutic area
Cardiology
Rare disease
No
- Definition
- Necrosis of the myocardium, as a result of interruption of the blood supply to the area. It is characterized by a severe and rapid onset of symptoms that may include chest pain, often radiating to the left arm and left side of the neck, dyspnea, sweating, and palpitations.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Acute myocardial infarction
- Therapeutic area
- Cardiology
- acute myocardial infarction
- acute myocardial infarction (disease)
- myocardial infarction (disease), acute
- All therapeutic areas
- Cardiology
- Severity
- Severe
- MONDO ID
- MONDO:0004781
- Parent condition
- MONDO:0005068
Related records
Broader conditions (8)
- Acute disease
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Heart disorder
- Human disease
- Myocardial disorder
- Myocardial infarction
Narrower conditions (6)
- Acute anterolateral myocardial infarction
- Acute inferolateral myocardial infarction
- Acute inferoposterior infarction
- Acute subendocardial myocardial infarction
- ST-elevation myocardial infarction
- Strictly posterior acute myocardial infarction
Trials (668)
- "ESTIMATION Study" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction
- 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis
- A Behavioral Economics-Based Telehealth Intervention to Improve Post-MI Medication Adherence
- A Case-control Study of Costa Rican Adults With Myocardial Infarction
- A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital
- A Comparison of p53-induced Genes Activation in Patients With and Without Acute Myocardial Infarction
- A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation
- A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack
- A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial
- A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
- A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction
- A Pilot Study of Transcoronary Myocardial Cooling
- A Polypill for Secondary Prevention of Ischemic Heart Disease
- A Registry Study on Genetics and Biomarkers of Acute Coronary Syndrome
- A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks
- A Study of Acute Myocardial Infarction Using FDY-5301
- A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
- A Study of CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment
- A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention
- A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
Approved drugs (9)
- Aspirin
- Atorvastatin calcium
- Enoxaparin sodium
- Eptifibatide
- Ramipril
- Simvastatin
- Tenecteplase
- Ticagrelor
- Valsartan
Drugs in development (47)
- .ALPHA.1-proteinase inhibitor human Phase 1
- Abciximab Phase 3
- Acetylcysteine Phase 3
- Adenosine Phase 3
- Anakinra Phase 3
- Bivalirudin Phase 3
- Clopidogrel Phase 3
- Cyclosporine Phase 3
- Darbepoetin alfa Phase 3
- Deferiprone Phase 1
- Edoxaban Phase 2
- Elamipretide hydrochloride Phase 2
- Empagliflozin Phase 3
- Epoetin beta Phase 3
- Ethylene Phase 2
- Exenatide Phase 3
- Filgrastim Phase 3
- Furosemide Phase 3
- Gelatin Phase 2
- Heme arginate Phase 1
Other linked drugs (5)
- Acetaminophen
- Atorvastatin
- Delcasertib
- Nicorandil
- Ridogrel